Milpitas, CA, United States of America

Zeeshan Kamal

This inventor holds 4 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: Mayo Foundation for Medical Education and Research, Nanosys, Inc.. Active years: 2022-2025.

USPTO Granted Patents = 4 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Zeeshan Kamal: Innovator in Lipase Inhibitors

Introduction

Zeeshan Kamal is a prominent inventor based in Milpitas, CA (US). He has made significant contributions to the field of medical research, particularly in the development of novel lipase inhibitors. With a total of 4 patents, his work focuses on addressing critical health issues through innovative solutions.

Latest Patents

Kamal's latest patents include compounds aimed at reducing lipotoxic damage. These patents describe novel lipase inhibitors and methods for their use in treating various conditions such as inflammation, multisystem organ failure, necrotic pancreatic acinar cell death, acute pancreatitis, sepsis, burns, and acne. The patents detail two specific lipase inhibitors that are useful in these therapeutic methods.

Career Highlights

Throughout his career, Zeeshan Kamal has worked with esteemed organizations such as the Mayo Foundation for Medical Education and Research and Nanosyn, Inc. His experience in these institutions has allowed him to refine his expertise and contribute to groundbreaking research in the medical field.

Collaborations

Kamal has collaborated with notable professionals in his field, including Vijay Prem Singh and Sampath-Kumar Anandan. These partnerships have further enhanced his research and development efforts.

Conclusion

Zeeshan Kamal is a dedicated inventor whose work in lipase inhibitors has the potential to make a significant impact on medical treatments. His innovative approach and collaboration with other experts highlight his commitment to advancing healthcare solutions.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…